After the discovery of Helicobacter pylori (H. pylori), and the evidence of its relationship with
gastric diseases, antibiotic-based therapies were developed, which efficacy was however …

Over 80% of individuals infected with Helicobacter pylori (H. pylori) are asymptomatic.
Increased resistance to antibiotics and decreased compliance to the therapeutic regimens …

Many new therapeutic strategies are studied to improve Helicobacter pylori eradication rate.
Probiotics are live microorganisms which, upon administration, may interact with the human …

Background: Helicobacter pylori is a prevalent pathogen which is considered as an
etiological cause for gastroduodenal ulcers, and a substantial risk factor for gastric …

Objective: To review the literature on the role of probiotics as adjunctive therapy in the
treatment of Helicobacter pylori infections. Data Sources: Literature was accessed through …

Probiotics are defined as,“Live microorganisms that, when administered in adequate
amounts, confer a health benefit on the host”, and have various effects including inhibitory …

The role of probiotics in the treatment of gastrointestinal infections is increasingly being
documented as an alternative or complement to antibiotics, with the potential to decrease …

AIM: To summarize the evidence from randomized controlled trials (RCTs) regarding the
effect of probiotics by using a meta-analytic approach. METHODS: In July 2013, we …

Helicobacter pylori is a Gram-negative microorganism that causes chronic dyspepsia,
gastritis, mucosaassociated lymphoid tissue (MALT) lymphoma, and gastric …

Helicobacter pylori, a pathogenic bacterium, has been known to be the root cause of
numerous gastrointestinal disorders. In patients showing symptoms of its infection, antibiotic …